Home/Filings/4/0001578563-23-000065
4//SEC Filing

BAYER AKTIENGESELLSCHAFT 4

Accession 0001578563-23-000065

CIK 0001701478other

Filed

Jul 23, 8:00 PM ET

Accepted

Jul 24, 5:51 PM ET

Size

12.6 KB

Accession

0001578563-23-000065

Insider Transaction Report

Form 4
Period: 2023-06-21
Transactions
  • Conversion

    Series B Convertible Preferred Stock

    2023-06-211,307,4010 total
    Common Stock (1,307,401 underlying)
  • Conversion

    Common Stock

    2023-06-21+1,307,4011,307,401 total
Transactions
  • Conversion

    Common Stock

    2023-06-21+1,307,4011,307,401 total
  • Conversion

    Series B Convertible Preferred Stock

    2023-06-211,307,4010 total
    Common Stock (1,307,401 underlying)
Transactions
  • Conversion

    Common Stock

    2023-06-21+1,307,4011,307,401 total
  • Conversion

    Series B Convertible Preferred Stock

    2023-06-211,307,4010 total
    Common Stock (1,307,401 underlying)
Transactions
  • Conversion

    Series B Convertible Preferred Stock

    2023-06-211,307,4010 total
    Common Stock (1,307,401 underlying)
  • Conversion

    Common Stock

    2023-06-21+1,307,4011,307,401 total
Footnotes (2)
  • [F1]Each share of Series B Convertible Preferred Stock automatically converted into shares of common stock of the Issuer upon the closing of the Issuer's IPO at a conversion price equal to approximately $1.11 per share, after making certain anti-dilution adjustments. The Series B Convertible Preferred Stock had no expiration date.
  • [F2]The securities reported are held directly by Bayer HealthCare LLC, a Delaware limited liability company, which is controlled by Bayer US Holding LP ("BUSH LP"), a Delaware limited partnership. Bayer World Investments B.V. ("BWI"), a Dutch private limited company, is the general partner of BUSH LP. BWI is an indirect, wholly owned subsidiary of Bayer Aktiengesellschaft, a publicly-held German stock corporation. Accordingly, Bayer Aktiengesellschaft may be deemed to be an indirect beneficial owner of the shares beneficially owned directly by Bayer HealthCare LLC.

Issuer

Azitra Inc

CIK 0001701478

Entity typeother

Related Parties

1
  • filerCIK 0001144145

Filing Metadata

Form type
4
Filed
Jul 23, 8:00 PM ET
Accepted
Jul 24, 5:51 PM ET
Size
12.6 KB